Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Guardant Health, Inc.GH · Entity 3238 | Director | May 18, 2020 | May 20, 2020 |
| Relay Therapeutics, Inc.RLAY · Entity 4044 | Director | July 15, 2020 | July 16, 2020 |
| Seer, Inc.SEER · Entity 6717 | Director | July 28, 2026 | July 30, 2026 |
| Senti Biosciences Holdings, Inc.DYNS · Entity 7935 | Director | May 25, 2021 | May 26, 2021 |
| Vir Biotechnology, Inc.VIR · Entity 4522 | Director | May 21, 2021 | May 25, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Guardant Health, Inc.
Report date May 18, 2020 · Filed May 20, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMON STOCKSEC Table I · non-derivative | Direct | 2,321 |
Reported balance
After 2020-05-18 transaction · row 1
1 source rowRow 1 · 2020-05-18 · Sale · Disposed 2 · Balance 2,321 F1: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. |
| COMMON STOCKSEC Table I · non-derivative | IndirectA family corporation | 661 |
Reported balance
Holding disclosure · report date 2020-05-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 661 F2: These securities are held by a family corporation controlled by Mr. Nishar. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2: These securities are held by a family corporation controlled by Mr. Nishar.
Relay Therapeutics, Inc.
Report date July 15, 2020 · Filed July 16, 2020
This filing explicitly reported no securities owned.
Seer, Inc.
Report date July 28, 2026 · Filed July 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 75,544 |
Reported balance
After 2026-07-28 transaction · row 1
1 source rowRow 1 · 2026-07-28 · Grant · Acquired 16,500 · Balance 75,544 F1: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) July 28, 2027 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.14 · Expires 2036-07-28 | Direct | 25,000 |
Reported balance
After 2026-07-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-28 · Grant · Acquired 25,000 · Balance 25,000 F2: Shares subject to the option vest on the earlier of (i) July 28, 2027 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) July 28, 2027 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders.
F2: Shares subject to the option vest on the earlier of (i) July 28, 2027 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders.
Senti Biosciences Holdings, Inc.
Report date May 25, 2021 · Filed May 26, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stockSEC Table I · non-derivative | IndirectSee footnote | 10,733 |
Reported balance
Holding disclosure · report date 2021-05-25 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 10,733 F1: Up to 900 of these shares of Class A common stock will be forfeited in the event the underwriters for the Issuer's initial public offering do not exercise in full their overallotment option in connection with that offering, all as described in the Issuer's prospectus on Form S-1 filed on May 7, 2021 (the "Prospectus"). F2: Dynamics Sponsor LLC, a Delaware limited liability company, (the "Sponsor") is the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi who hold an economic interest therein. Any action by the Sponsor with respect to Issuer or the shares reported above, including voting and dispositive decisions, requires unanimous approval of the managers. |
| Class B common stockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | IndirectSee Footnote | Not disclosed |
Reported balance
Holding disclosure · report date 2021-05-25 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F3: These shares of Class B common stock will automatically convert on a one-for-one basis (subject to adjustment) into Class A common stock for no additional consideration at the time of the initial business combination by the Issuer, subject to the adjustments described in the Prospectus. The shares of Class B Common Stock have no expiration date. F4: Up to 4,894 of these shares of Class B common stock will be forfeited in the event the underwriters for the Issuer's initial public offering do not exercise in full their overallotment option in connection with that offering, all as described in the Prospectus. F2: Dynamics Sponsor LLC, a Delaware limited liability company, (the "Sponsor") is the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi who hold an economic interest therein. Any action by the Sponsor with respect to Issuer or the shares reported above, including voting and dispositive decisions, requires unanimous approval of the managers. |
Filing footnotes · ownership attribution and instrument terms
F1: Up to 900 of these shares of Class A common stock will be forfeited in the event the underwriters for the Issuer's initial public offering do not exercise in full their overallotment option in connection with that offering, all as described in the Issuer's prospectus on Form S-1 filed on May 7, 2021 (the "Prospectus").
F2: Dynamics Sponsor LLC, a Delaware limited liability company, (the "Sponsor") is the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi who hold an economic interest therein. Any action by the Sponsor with respect to Issuer or the shares reported above, including voting and dispositive decisions, requires unanimous approval of the managers.
F3: These shares of Class B common stock will automatically convert on a one-for-one basis (subject to adjustment) into Class A common stock for no additional consideration at the time of the initial business combination by the Issuer, subject to the adjustments described in the Prospectus. The shares of Class B Common Stock have no expiration date.
F4: Up to 4,894 of these shares of Class B common stock will be forfeited in the event the underwriters for the Issuer's initial public offering do not exercise in full their overallotment option in connection with that offering, all as described in the Prospectus.
Vir Biotechnology, Inc.
Report date May 21, 2021 · Filed May 25, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,374 |
Reported balance
After 2021-05-21 transaction · row 1
1 source rowRow 1 · 2021-05-21 · Grant · Acquired 3,374 · Balance 3,374 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.28 · Expires 2031-05-20 | Direct | 6,748 |
Reported balance
After 2021-05-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-05-21 · Grant · Acquired 6,748 · Balance 6,748 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TripAdvisor, Inc.
Report date June 21, 2019 · Filed June 25, 2019
Section 16 reporting ended · disclosed 2019-06-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,059 |
Reported balance
After 2019-06-21 transaction · row 1
1 source rowRow 1 · 2019-06-21 · Disposition to issuer · Disposed 2,192 · Balance 15,059 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 28, 2026 Filed Jul 30, 2026 20:19 UTC | Seer, Inc. SEER · Entity 6717 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001519500-26-000004 · form4-07302026_080718.xml · derivative · entry 2 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Class A Common Stock · 25,000 shares Expires 2036-07-28 F2 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) July 28, 2027 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| July 28, 2026 Filed Jul 30, 2026 20:19 UTC | Seer, Inc. SEER · Entity 6717 | GrantClass A Common Stock | 16,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001519500-26-000004 · form4-07302026_080718.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,544 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) July 28, 2027 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| July 08, 2026 Filed Jul 10, 2026 22:23 UTC | Seer, Inc. SEER · Entity 6717 | SaleClass A Common Stock | 10,660 | $2.18 | $23,265.45 |
DisclosureSEC source: 0001519500-26-000002 · form4-07102026_100706.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,044 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025 to cover tax obligations upon the vesting and settlement of restricted stock units. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.17 to $2.22, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 07, 2025 Filed Jul 9, 2025 20:13 UTC | Seer, Inc. SEER · Entity 6717 | GrantStock Option (right to buy) · Derivative | 30,500 | $0.00 Strike: $2.18 | $0.00 |
DisclosureSEC source: 0001415889-25-019575 · form4-07092025_080759.xml · derivative · entry 2 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,500 Underlying: Class A Common Stock · 30,500 shares Expires 2035-07-07 F2 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) July 7, 2026 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| July 07, 2025 Filed Jul 9, 2025 20:13 UTC | Seer, Inc. SEER · Entity 6717 | GrantClass A Common Stock | 20,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-019575 · form4-07092025_080759.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,704 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) July 7, 2026 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 22:32 UTC | Seer, Inc. SEER · Entity 6717 | SaleClass A Common Stock | 30,253 | $2.08 | $62,935.32 |
DisclosureSEC source: 0001415889-25-017434 · form4-06162025_100649.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,204 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.055 to $2.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 14, 2024 Filed Jun 19, 2024 00:00 UTC | Seer, Inc. SEER · Entity 6717 | SaleClass A Common Stock | 12,109 | $1.78 | $21,511.64 |
DisclosureSEC source: 0001415889-24-017505 · form4-06192024_120628.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,457 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.74 to $1.82, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 20:29 UTC | Seer, Inc. SEER · Entity 6717 | GrantClass A Common Stock | 58,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-016923 · form4-06142024_080608.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,566 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 12, 2025 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 14, 2023 Filed Jun 17, 2023 01:19 UTC | Seer, Inc. SEER · Entity 6717 | GrantStock Option (right to buy) · Derivative | 34,735 | $0.00 Strike: $4.33 | $0.00 |
DisclosureSEC source: 0001209191-23-038197 · doc4.xml · derivative · entry 2 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,735 Underlying: Class A Common Stock · 34,735 shares Expires 2033-06-14 F2 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 14, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 14, 2023 Filed Jun 17, 2023 01:19 UTC | Seer, Inc. SEER · Entity 6717 | GrantClass A Common Stock | 23,443 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-038197 · doc4.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,388 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 14, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:51 UTC | Seer, Inc. SEER · Entity 6717 | GrantStock Option (right to buy) · Derivative | 29,640 | $0.00 Strike: $7.33 | $0.00 |
DisclosureSEC source: 0001209191-22-038127 · doc4.xml · derivative · entry 2 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,640 Underlying: Class A Common Stock · 29,640 shares Expires 2031-06-15 F2 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 15, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:51 UTC | Seer, Inc. SEER · Entity 6717 | GrantClass A Common Stock | 9,945 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038127 · doc4.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,945 F1 · shares: The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 15, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 21:43 UTC | Seer, Inc. SEER · Entity 6717 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $13.84 | $0.00 |
DisclosureSEC source: 0001209191-22-015503 · doc4.xml · derivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Class A Common Stock · 30,000 shares Expires 2032-03-02 F1 · derivative.exercise_date: Shares subject to the option vest in 36 equal monthly installments beginning on April 1, 2022. Read SEC document |
| May 21, 2021 Filed May 25, 2021 20:45 UTC | Vir Biotechnology, Inc. VIR · Entity 4522 | GrantStock Option (Right to Buy) · Derivative | 6,748 | $0.00 Strike: $45.28 | $0.00 |
DisclosureSEC source: 0001209191-21-035712 · doc4.xml · derivative · entry 2 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,748 Underlying: Common Stock · 6,748 shares Expires 2031-05-20 Read SEC document |
| May 21, 2021 Filed May 25, 2021 20:45 UTC | Vir Biotechnology, Inc. VIR · Entity 4522 | GrantCommon Stock | 3,374 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-035712 · doc4.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,374 Read SEC document |
| May 21, 2020 Filed May 26, 2020 21:00 UTC | Vir Biotechnology, Inc. VIR · Entity 4522 | GrantStock Option (Right to Buy) · Derivative | 28,888 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-032061 · doc4.xml · derivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,888 Underlying: Common Stock · 28,888 shares Expires 2030-05-21 Read SEC document |
| May 21, 2020 Filed Oct 13, 2020 23:11 UTC Amendment | Vir Biotechnology, Inc. VIR · Entity 4522 | GrantStock Option (Right to Buy) · Derivative | 24,885 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-054738 · doc4a.xml · derivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,885 Underlying: Common Stock · 24,885 shares Expires 2030-05-20 Read SEC document |
| May 18, 2020 Filed May 20, 2020 21:16 UTC | Guardant Health, Inc. GH · Entity 3238 | SaleCOMMON STOCK | 2 | $100.00 | $200.00 |
DisclosureSEC source: 0001628280-20-008134 · wf-form4_159000935261247.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,321 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:05 UTC | Guardant Health, Inc. GH · Entity 3238 | OtherCOMMON STOCK | 331 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-002800 · wf-form4_158327310586082.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · A family corporation Disclosed balance after: 661 F1 · kind: Represents the receipt of shares of Common Stock of the Issuer by virtue of a pro-rata distribution from Mr. Nishar's investment in an investment fund. F2 · ownership.nature: These securities are held by a family corporation controlled by Mr. Nishar. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 22:05 UTC | Guardant Health, Inc. GH · Entity 3238 | OtherCOMMON STOCK | 165 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-002585 · wf-form4_158292749504304.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · A family corporation Disclosed balance after: 330 F1 · kind: Represents the receipt of shares of Common Stock of the Issuer by virtue of a pro-rata distribution from Mr. Nishar's investment in an investment fund. F2 · ownership.nature: These securities are held by a family corporation controlled by Mr. Nishar. Read SEC document |
| December 17, 2019 Filed Dec 20, 2019 00:13 UTC | Guardant Health, Inc. GH · Entity 3238 | OtherCOMMON STOCK | 165 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-015242 · wf-form4_157680081359079.xml · nonDerivative · entry 2 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · A family corporation Disclosed balance after: 165 F1 · kind: Represents the receipt of shares of Common Stock of the Issuer by virtue of a pro-rata distribution from Mr. Nishar's investment in an investment fund. F2 · ownership.nature: These securities are held by a family corporation controlled by Mr. Nishar. Read SEC document |
| December 17, 2019 Filed Dec 20, 2019 00:13 UTC | Guardant Health, Inc. GH · Entity 3238 | OtherCOMMON STOCK | 31 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-015242 · wf-form4_157680081359079.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,323 F1 · kind: Represents the receipt of shares of Common Stock of the Issuer by virtue of a pro-rata distribution from Mr. Nishar's investment in an investment fund. Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 20:58 UTC | Guardant Health, Inc. GH · Entity 3238 | OtherCOMMON STOCK | 330 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-011360 · wf-form4_156754431833772.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,292 F1 · kind: Represents the receipt of shares of Common Stock of the Issuer by virtue of a pro-rata distribution from Mr. Nishar's investment in an investment fund. Read SEC document |
| August 21, 2019 Filed Aug 23, 2019 21:18 UTC | Guardant Health, Inc. GH · Entity 3238 | OtherCOMMON STOCK | 330 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-011161 · wf-form4_156659511405476.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,962 F1 · kind: Represents the receipt of shares of Common Stock of the Issuer by virtue of a pro-rata distribution from Mr. Nishar's investment in an investment fund. Read SEC document |
| August 09, 2019 Filed Aug 16, 2019 01:05 UTC | Guardant Health, Inc. GH · Entity 3238 | OtherCOMMON STOCK | 330 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-010847 · wf-form4_156591749055828.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,632 F1 · kind: Represents the receipt of shares of Common Stock of the Issuer by virtue of a pro-rata distribution from Mr. Nishar's investment in an investment fund. Read SEC document |
| June 21, 2019 Filed Jun 25, 2019 22:05 UTC | TripAdvisor, Inc. TRIP · Entity 4890 | Disposition to issuerCommon Stock | 2,192 | $46.80 | $102,585.60 |
DisclosureSEC source: 0001127602-19-022808 · form4.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,059 Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 22:11 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 2,255 | $0.00 Strike: $91.11 | $0.00 |
DisclosureSEC source: 0001628280-19-008203 · wf-form4_156106864893131.xml · derivative · entry 2 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,255 Underlying: COMMON STOCK · 2,255 shares Expires 2029-06-17 F1 · derivative.exercise_date: The stock option vests in full on the earlier to occur of (i) June 18, 2020 and (ii) the date of the next annual meeting of the Issuer's stockholders. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 22:11 UTC | Guardant Health, Inc. GH · Entity 3238 | GrantCOMMON STOCK | 1,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-008203 · wf-form4_156106864893131.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,302 Read SEC document |
| June 22, 2018 Filed Jun 26, 2018 12:46 UTC | TripAdvisor, Inc. TRIP · Entity 4890 | SaleCommon Stock | 3,497 | $57.12 | $199,748.64 |
DisclosureSEC source: 0001127602-18-021883 · form4.xml · nonDerivative · entry 2 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,251 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by this reporting person. F2 · price: The transaction was executed in multiple trades with a weighted average sales price of $57.12. The reporting person undertakes to provide information regarding the number of shares and prices at which the transactions were effected upon appropriate request. Read SEC document |
| June 21, 2018 Filed Jun 26, 2018 12:46 UTC | TripAdvisor, Inc. TRIP · Entity 4890 | GrantCommon Stock | 4,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-021883 · form4.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,748 Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 22:09 UTC | TripAdvisor, Inc. TRIP · Entity 4890 | SaleCommon Stock | 346 | $34.50 | $11,937.00 |
DisclosureSEC source: 0001127602-17-034953 · form4.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,371 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by this reporting person. Read SEC document |
| June 22, 2017 Filed Jun 28, 2017 23:41 UTC | TripAdvisor, Inc. TRIP · Entity 4890 | GrantCommon Stock | 6,994 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-022313 · form4.xml · nonDerivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,994 F1 · security: Represents shares underlying Restricted Stock Units ("RSUs") granted under the Company's Amended and Restated 2011 Stock and Annual Incentive Plan, in connection with such individual's election to the Company's Board of Directors. Such RSUs to vest in full on the first anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.